Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells

Molecular and Cellular Endocrinology

Volumn 263, Issue 1-2, 2007, Pages 90-102

  Kageyama, Kazunori ^a   Hanada, Komaki ^a   Moriyama, Takako ^a   Imaizumi, Tadaatsu ^a   Satoh, Kei ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Aorta; Corticotroph; Corticotropin releasing factor; Corticotropin releasing factor receptor; Cyclic AMP; Pituitary; Urocortin

Indexed keywords

BISINDOLYLMALEIMIDE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; UROCORTIN; UROCORTIN 1; UROCORTIN 2;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; INDOLES; MALEIMIDES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PITUITARY GLAND; PROTEIN KINASE C; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION;

EID: 34247535852     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.08.011     Document Type: Article

References (42)

1. Aggelidou E., Hillhouse E.W., and Grammatopoulos D.K. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3300-3305
2. Brar B.K., Jonassen A.K., Stephanou A., Santilli G., Railson J., Knight R.A., Yellon D.K., and Latchman D.S. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J. Biol. Chem. 275 (2000) 8508-8514
3. Brar B.K., Chen A., Perrin M.H., and Vale W. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology 145 (2004) 1718-1729
4. Chang L., and Karin M. Mammalian MAP kinase signaling cascades. Nature 410 (2001) 37-40
5. Cibelli G., Corsi P., Diana G., Vitiello F., and Thiel G. Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur. J. Neurosci. 13 (2001) 1339-1348
6. Cospedal R., Lobo M., and Zachary I. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rat vascular smooth muscle cells. Biochem. J. 342 (1999) 407-414
7. Gordon J.M., Dusting G.J., Woodman O.L., and Ritchie R.H. Cardioprotective action of CRF peptide urocortin against simulated ischemia in adult rat cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H330-H336
8. Dermitzaki E., Tsatsanis C., Charalampopoulos I., Androulidaki A., Alexaki V.I., Castanas E., Gravanis A., and Margioris A.N. Corticotropin-releasing hormone activates protein kinase C in an isoenzyme-specific manner. Biochem. Biophys. Res. Commun. 327 (2005) 828-836
9. Hauger R.L., Olivares-Reyes J.A., Braun S., Catt K.J., and Dautzenberg F.M. Mediation of corticotropin releasing factor type 1 receptor phosphorylation and desensitization by protein kinase C: a possible role in stress adaptation. J. Pharmacol. Exp. Ther. 306 (2003) 794-803
10. Hillhouse E.W., and Grammatopoulos D.K. Control of intracellular signalling by corticotropin-releasing hormone in human myometrium. Front. Horm. Res. 27 (2001) 66-74
11. Hsu S.Y., and Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 7 (2001) 605-611
12. Kageyama K., Bradbury M.J., Zhao L., Blount A.L., and Vale W.W. Urocortin messenger ribonucleic acid: tissue distribution in the rat and regulation in thymus by lipopolysaccharide and glucocorticoids. Endocrinology 140 (1999) 5651-5658
13. Kageyama K., Gaudriault G.E., Suda T., and Vale W.W. Regulation of corticotropin-releasing factor receptor type 2β mRNA via cyclic AMP pathway in A7r5 aortic smooth muscle cells. Cell Signal 15 (2003) 17-25
14. Kageyama K., Li C., and Vale W.W. Corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in rat pituitary: localization and regulation by immune challenge, restraint stress, and glucocorticoids. Endocrinology 144 (2003) 1524-1532
15. Kageyama K., Furukawa K.-I., Miki I., Terui K., Motomura S., and Suda T. Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. J. Cardiovasc. Pharmacol. 42 (2003) 561-565
16. Kageyama K., and Suda T. Urocortin-related peptides increase interleukin-6 output via cyclic adenosine 5′-monophosphate-dependent pathways in A7r5 aortic smooth muscle cells. Endocrinology 144 (2003) 2234-2241
17. Kageyama K., Hanada K., and Suda T. Regulation of corticotropin-releasing factor receptor type 2β mRNA by mitogen-activated protein kinases in aortic smooth muscle cells. Regul. Pep. 126 (2005) 223-231
18. Kageyama K., Hanada K., Moriyama T., Nigawara T., Sakihara S., and Suda T. G protein-coupled receptor kinase 2 involvement in desensitization of corticotropin-releasing factor (CRF) receptor type 1 by CRF in murine corticotrophs. Endocrinology 147 (2006) 441-450
19. Kageyama K., Kimura R., Suga S., Ogawa Y., Suda T., and Wakui M. Modulation of Ca(2+) influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Peptides 27 (2006) 1814-1819
20. Kasagi Y., Horiba N., Sakai K., Fukuda Y., and Suda T. Involvement of cAMP-response element binding protein in corticotropin-releasing factor (CRF)-induced down-regulation of CRF receptor 1 gene expression in rat anterior pituitary cells. J. Neuroendocrinol. 14 (2002) 587-592
21. Kishimoto T., Pearse II R.V., Lin C.R., and Rosenfield M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1108-1112
22. Kostich W.A., Chen A., Sperle K., and Largent B.L. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor. Mol. Endocrinol. 12 (1998) 1077-1085
23. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., and Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7570-7575
24. Li C., Chen P., Vaughan J., Blount A., Chen A., Jamieson P.M., Rivier J., Smith M.S., and Vale W. Urocortin III is expressed in pancreatic beta-cells and stimulates insulin and glucagon secretion. Endocrinology 144 (2003) 3216-3224
25. Li H., Robinson P.J., Kawashima S., Funder J.W., and Liu J.P. Differential regulation of MAP kinase activity by corticotropin-releasing hormone in normal and neoplastic corticotropes. Int. J. Biochem. Cell Biol. 30 (1998) 1389-1401
26. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., and Oltersdolf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 836-840
27. Lubomirov L., Gagov H., Petkova-Kirova P., Duridanova D., Kalentchuk V.U., and Schubert R. Urocortin relaxes rat tail arteries by a PKA-mediated reduction of the sensitivity of the contractile apparatus for calcium. Br. J. Pharmacol. 134 (2001) 1564-1570
28. 1 receptor) mRNA via protein kinase A and mitogen-activated protein kinase pathways in rat anterior pituitary cells. Mol. Cell. Endocrinol. 243 (2005) 74-79
29. Parkes D.G., Vaughan J., Rivier J., Vale W., and May C.N. Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol. 272 (1997) H2115-H2122
30. Pedersen W.A., Wan R., Zhang P., and Mattson M.P. Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I. J. Neurosci. 22 2 (2002) 404-412
31. Pozzoli G., Bilezikjian L.M., Perrin M.H., Blount A.L., and Vale W.W. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137 (1996) 65-71
32. Reisine T., and Guild S. Activators of protein kinase C and cyclic AMP-dependent protein kinase regulate intracellular calcium levels through distinct mechanisms in mouse anterior pituitary tumor cells. Mol. Pharmacol. 32 (1987) 488-496
33. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., and Sawchenko P.E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 2843-2848
34. Rossant C.J., Pinnock R.D., Hughes J., Hall M.D., and McNulty S. Corticotropin-releasing factor type 1 and 2α receptors regulate phosphorylation of calcium/cyclic adenosine 3′,5′-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase. Endocrinology 140 (1999) 1525-1536
35. Sakai K., Horiba N., Sakai Y., Tozawa F., Demura H., and Suda T. Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary. Endocrinology 137 (1996) 1758-1763
36. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., and Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273 (1996) 1561-1564
37. Suda T., Kageyama K., Sakihara S., and Nigawara T. Physiological roles of urocortins, human homologues of fish urotensin 1, and their receptors. Peptides 25 (2004) 1689-1701
38. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213 (1981) 1394-1397
39. Vale W., Vaughan J., and Perrin M.H. Corticotropin-releasing factor (CRF) family ligands and their receptors. Endocrinologist 7 (1997) 3S-9S
40. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., and Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 (1995) 287-292
41. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., and Stork P.J.S. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89 (1997) 73-82
42. Vyas S., Bishop J.F., Gehlert D.R., and Patel J. Effects of protein kinase C down-regulation on secretory events and proopiomelanocortin gene expression in anterior pituitary tumor (AtT-20) cells. J. Neurochem. 54 (1990) 248-255